CellWell record HH-50989
Indications, usage, and dosage of the transfer factor
Berrón-Pérez R; Chávez-Sánchez R; Estrada-García I; Espinosa-Padilla S; Cortez-Gómez R; Serrano-Miranda E; Ondarza-Aguilera R; Pérez-Tapia M; Pineda Olvera B; Jiménez-Martínez Mdel C; Portugués A; Rodríguez A; Cano L; Pacheco PU; Barrientos J; Chacón R; Serafín J; Mendez P; Monges A; Cervantes E; Estrada-Parra S
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) · 2007
In plain language
In a review of clinical and animal studies, transfer factor was associated with increased IFN-gamma and RANTES expression and decreased osteopontin expression, and was used across conditions including herpes, tuberculosis, and dermatitis in protocol-based studies.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-50989
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.